FHO Partners’ asset advisory group has executed nine leases for life science companies totaling more than 100,000 square feet at One Kendall Square in Cambridge.

The transactions, listed below, are a mix of relocations, lease renewals and expansions for a variety of life science companies.

New leases include: Foundation Medicine (22,506 square feet); NinePoint Medical (17,105 square feet); Visterra (11,750 square feet); Ra Pharmaceuticals
(6,288 square feet); and Firefly Bioworks (1,980 square feet).

Merrimack Pharmaceuticals expanded to 11,878 square feet and Addgene increased its space to 7,145 square feet, according to a statement.

IDENIX Pharmaceuticals and Cequent Pharmaceuticals renewed for 22,500 square feet and 4,782 square feet, respectively.

"One Kendall Square continues to attract a remarkable level of tenant interest and activity given its quality space and unparalleled access to a variety of amenities, public transportation and key clusters of businesses in Kendall Square," said FHO Partners’ Duncan Gratton, co-head of the asset advisory group.

"It is gratifying when the market tells you your vision and business plan are correct. Our recent success at One Kendall has been the product of several years of work and planning, a true team effort," said Stephen Faber, senior vice president of the Beal Cos.